Dziopa, K., Asselbergs, F. W., Gratton, J., Chaturvedi, N., & Schmidt, A. F. (2022). Cardiovascular risk prediction in type 2 diabetes: a comparison of 22 risk scores in primary care settings. Diabetologia. doi:10.1007/s00125-021-05640-y

Schmidt, A. F., Hunt, N. B., Gordillo-Marañón, M., Charoen, P., Drenos, F., Kivimaki, M., . . . Finan, C. (2021). Cholesteryl ester transfer protein (CETP) as a drug target for cardiovascular disease. Nature Communications, 12 (1), 5640. doi:10.1038/s41467-021-25703-3

Schmidt, A. F., Finan, C., Gordillo-Marañón, M., Asselbergs, F. W., Freitag, D. F., Patel, R. S., . . . Hingorani, A. D. (2020). Genetic drug target validation using Mendelian randomisation. Nature Communications, 11 (1). doi:10.1038/s41467-020-16969-0

Schmidt, A. F., Carter, J. -. P. L., Pearce, L. S., Wilkins, J. T., Overington, J. P., Hingorani, A. D., & Casas, J. P. (2020). PCSK9 monoclonal antibodies for the primary and secondary prevention of cardiovascular disease. Cochrane Database Syst Rev, 10, CD011748. doi:10.1002/14651858.CD011748.pub3

Schmidt, A. F., Heerspink, H. J. L., Denig, P., Finan, C., & Groenwold, R. H. H. (2019). When drug treatments bias genetic studies: Mediation and interaction. PLoS One, 14 (8), e0221209. doi:10.1371/journal.pone.0221209

Schmidt, A. F., & Finan, C. (2018). Linear regression and the normality assumption. JOURNAL OF CLINICAL EPIDEMIOLOGY, 98, 146-151. doi:10.1016/j.jclinepi.2017.12.006

Schmidt, A. F., & Dudbridge, F. (2018). Mendelian randomization with Egger pleiotropy correction and weakly informative Bayesian priors. INTERNATIONAL JOURNAL OF EPIDEMIOLOGY, 47 (4), 1217-1228. doi:10.1093/ije/dyx254

Schmidt, A. F., Swerdlow, D. I., Holmes, M. V., Patel, R. S., Fairhurst-Hunter, Z., Lyall, D. M., . . . Pare, G. (2017). PCSK9 genetic variants and risk of type 2 diabetes: a mendelian randomisation study. The Lancet Diabetes and Endocrinology, 5 (2), 97-105. doi:10.1016/S2213-8587(16)30396-5

Schmidt, A. F., Joshi, R., Gordillo-Marañón, M., Drenos, F., Charoen, P., Giambartolomei, C., . . . Finan, C. (2023). Biomedical consequences of elevated cholesterol-containing lipoproteins and apolipoproteins on cardiovascular and non-cardiovascular outcomes. Communications Medicine, 3 (1), 9. doi:10.1038/s43856-022-00234-0

Schmidt, A., Finan, C., Bourfiss, M., Velthuis, B., Puyol-Antón, E., Alasiri, A., . . . van Setten, J. (2023). Cardiac MRI to guide heart failure and atrial fibrillation drug discovery: a Mendelian randomization analysis. doi:10.21203/rs.3.rs-2449265/v1